Monash IVF shares cater 25% – Disaster or deep-value play?
Monash IVF Group (ASX:MVF) is back in the headlines, and for all the wrong reasons. Shares have plunged 25% following news of a second embryo mix-up this year, and for many investors, it’s déjà vu.Listen to the HotCopper podcast for in-depth discussions and insights on all the big...
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online